NCT05278728 2025-02-07
Phase IIa Study of Nimotuzumab to Treat Colorectal Cancer
Biotech Pharmaceutical Co., Ltd.
Phase 1/2 Completed
Clinical Trials
4 trialsNCT02095119 2015-04-14
A Monoclonal Antibody, Nimotuzumab, as Treatment for Recurrent or Metastatic Cervical Cancer
National Institute of Cancerología
Phase 1/2 Completed
NCT01993784 2013-11-25
Study of Nimotuzumab to Treat Esophageal Squamous Cell Carcinoma.
Peking University
Phase 1/2 Unknown
NCT00369447 2011-07-01
A Study of Nimotuzumab in Combination With External Radiotherapy in Non-Small Cell Lung Cancer
YM BioSciences
Phase 1/2 Terminated